These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22400034)

  • 21. CspA from Borrelia burgdorferi inhibits the terminal complement pathway.
    Hallström T; Siegel C; Mörgelin M; Kraiczy P; Skerka C; Zipfel PF
    mBio; 2013 Aug; 4(4):. PubMed ID: 23943762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins.
    Haupt K; Kraiczy P; Wallich R; Brade V; Skerka C; Zipfel PF
    J Infect Dis; 2007 Jul; 196(1):124-33. PubMed ID: 17538892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production, purification, and quality assessment of borrelial proteins CspZ from Borrelia burgdorferi and FhbA from Borrelia hermsii.
    Guérin M; Vandevenne M; Brans A; Matagne A; Marquant R; Prost E; Octave S; Avalle B; Maffucci I; Padiolleau-Lefèvre S
    Appl Microbiol Biotechnol; 2024 Jul; 108(1):425. PubMed ID: 39042328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.
    Hammerschmidt C; Koenigs A; Siegel C; Hallström T; Skerka C; Wallich R; Zipfel PF; Kraiczy P
    Infect Immun; 2014 Jan; 82(1):380-92. PubMed ID: 24191298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi.
    Bhattacharjee A; Oeemig JS; Kolodziejczyk R; Meri T; Kajander T; Lehtinen MJ; Iwaï H; Jokiranta TS; Goldman A
    J Biol Chem; 2013 Jun; 288(26):18685-95. PubMed ID: 23658013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates.
    Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
    Int Immunopharmacol; 2001 Mar; 1(3):393-401. PubMed ID: 11367524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.
    Kraiczy P; Seling A; Brissette CA; Rossmann E; Hunfeld KP; Bykowski T; Burns LH; Troese MJ; Cooley AE; Miller JC; Brade V; Wallich R; Casjens S; Stevenson B
    Clin Vaccine Immunol; 2008 Mar; 15(3):484-91. PubMed ID: 18160620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter- and intraspecies-specific adhesion of Lyme borreliae to human keratinocytes.
    Bigelmayr S; Koenigs A; Kraiczy P
    Ticks Tick Borne Dis; 2019 Jan; 10(1):207-212. PubMed ID: 30391124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ErpC, a member of the complement regulator-acquiring family of surface proteins from Borrelia burgdorferi, possesses an architecture previously unseen in this protein family.
    Caesar JJ; Johnson S; Kraiczy P; Lea SM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Jun; 69(Pt 6):624-8. PubMed ID: 23722838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle.
    Bykowski T; Woodman ME; Cooley AE; Brissette CA; Wallich R; Brade V; Kraiczy P; Stevenson B
    Int J Med Microbiol; 2008 Sep; 298 Suppl 1(Suppl 1):249-56. PubMed ID: 18165150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast, adaptive evolution at a bacterial host-resistance locus: the PFam54 gene array in Borrelia burgdorferi.
    Wywial E; Haven J; Casjens SR; Hernandez YA; Singh S; Mongodin EF; Fraser-Liggett CM; Luft BJ; Schutzer SE; Qiu WG
    Gene; 2009 Sep; 445(1-2):26-37. PubMed ID: 19505540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BGA66 and BGA71 facilitate complement resistance of Borrelia bavariensis by inhibiting assembly of the membrane attack complex.
    Hammerschmidt C; Klevenhaus Y; Koenigs A; Hallström T; Fingerle V; Skerka C; Pos KM; Zipfel PF; Wallich R; Kraiczy P
    Mol Microbiol; 2016 Jan; 99(2):407-24. PubMed ID: 26434356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Characterization of Borrelia burgdorferi Complement-Binding Proteins.
    Kraiczy P
    Methods Mol Biol; 2018; 1690():95-103. PubMed ID: 29032539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.
    Marcinkiewicz AL; Dupuis AP; Zamba-Campero M; Nowak N; Kraiczy P; Ram S; Kramer LD; Lin YP
    Cell Microbiol; 2019 Feb; 21(2):e12998. PubMed ID: 30571845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen.
    Hallström T; Haupt K; Kraiczy P; Hortschansky P; Wallich R; Skerka C; Zipfel PF
    J Infect Dis; 2010 Aug; 202(3):490-8. PubMed ID: 20565259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.
    Alitalo A; Meri T; Rämö L; Jokiranta TS; Heikkilä T; Seppälä IJ; Oksi J; Viljanen M; Meri S
    Infect Immun; 2001 Jun; 69(6):3685-91. PubMed ID: 11349031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1.
    Herzberger P; Siegel C; Skerka C; Fingerle V; Schulte-Spechtel U; van Dam A; Wilske B; Brade V; Zipfel PF; Wallich R; Kraiczy P
    Infect Immun; 2007 Oct; 75(10):4817-25. PubMed ID: 17635869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family.
    Kraiczy P; Hellwage J; Skerka C; Kirschfink M; Brade V; Zipfel PF; Wallich R
    Eur J Immunol; 2003 Mar; 33(3):697-707. PubMed ID: 12616490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inadequate binding of immune regulator factor H is associated with sensitivity of Borrelia lusitaniae to human complement.
    Dieterich R; Hammerschmidt C; Richter D; Skerka C; Wallich R; Matuschka FR; Zipfel PF; Kraiczy P
    Infect Immun; 2010 Nov; 78(11):4467-76. PubMed ID: 20823202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes.
    Xie J; Zhi H; Garrigues RJ; Keightley A; Garcia BL; Skare JT
    PLoS Pathog; 2019 Mar; 15(3):e1007659. PubMed ID: 30897158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.